Karin Helena Johansson Wingstrand
Director/Board Member bei INTEGRUM AB
Profil
Ms. Karin Helena Johansson Wingstrand is an Independent Director at Integrum AB and a Partner at Aqilion AB.
She is on the Board of Directors at Integrum AB, T-Bolaget AB, Histolab Products AB, Sahlgrenska Forskningsstiftelsen and Winkon Holding AB.
Ms. Johansson Wingstrand was previously employed as an Independent Director by Xbrane Biopharma AB and a Global Head-Clinical Research by AstraZeneca AB.
She also served on the board at Mevia AB, Adenovir Pharma AB, Swecure AB and Xintela AB.
She received her graduate degree from the University of Uppsala.
Aktive Positionen von Karin Helena Johansson Wingstrand
Unternehmen | Position | Beginn |
---|---|---|
INTEGRUM AB | Director/Board Member | 01.01.2019 |
T-Bolaget AB
T-Bolaget AB Financial ConglomeratesFinance T-Bolaget AB engages in investment and trading of securities, for a limited and closed group of owners. The company was founded on December 15, 1958 and is headquartered in Gothenburg, Sweden. | Director/Board Member | 01.01.2001 |
Sahlgrenska Forskningsstiftelsen | Director/Board Member | - |
Winkon Holding AB | Director/Board Member | - |
Aqilion AB
Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Private Equity Investor | 13.02.2014 |
Histolab Products AB | Director/Board Member | - |
Ehemalige bekannte Positionen von Karin Helena Johansson Wingstrand
Unternehmen | Position | Ende |
---|---|---|
XBRANE BIOPHARMA AB | Director/Board Member | 02.05.2024 |
XINTELA AB | Director/Board Member | 01.01.2022 |
Swecure AB | Director/Board Member | 01.01.2018 |
░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Karin Helena Johansson Wingstrand
University of Uppsala | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
XBRANE BIOPHARMA AB | Health Technology |
XINTELA AB | Health Technology |
INTEGRUM AB | Health Technology |
Private Unternehmen | 9 |
---|---|
T-Bolaget AB
T-Bolaget AB Financial ConglomeratesFinance T-Bolaget AB engages in investment and trading of securities, for a limited and closed group of owners. The company was founded on December 15, 1958 and is headquartered in Gothenburg, Sweden. | Finance |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Aqilion AB
Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Finance |
Sahlgrenska Forskningsstiftelsen | |
Swecure AB | Health Technology |
Mevia AB
Mevia AB Other Consumer ServicesConsumer Services Mevia AB provides drug package that helps patients manage their drug intake. It also provides intelligent solutions for medical treatments. The firm’s solutions address the greatest challenge in medical treatments improving adherence. The company also manages by increasing the patient support and providing personal adherence feedback in real time. Mevia works closely with their clients to develop innovative packaging and IT solutions that provide patients with the best possible experience. The company was founded by Linnea Olsson and Jesper Hassel and is headquartered in Gothenburg, Sweden. | Consumer Services |
Winkon Holding AB | |
Histolab Products AB | |
Adenovir Pharma AB
Adenovir Pharma AB Pharmaceuticals: MajorHealth Technology Adenovir Pharma AB provides solutions for the treatment of eye diseases. The firm offers treatments and business development opportunities to the pharmaceutical industry. It manufactures antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC). The company was founded by Per Niklas Arnberg on December 11, 2007 and is headquartered in Helsingborg, Sweden. | Health Technology |